CD274 and glioma: Flow cytometry analysis revealed that treatment of glioma cells with recombinant type I IFN or infection with VSVΔ51, but not treatment with TNF-α, resulted in the increased surface expression of PD-L1 and major histocompatibility complex (MHC) I markers.